CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 81 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | Francisco David Chief Financial Officer | Grant or award | +44,040 | 745,999 | ||
| 2026-02-18 | Francisco David Chief Financial Officer | Shares withheld for taxes | −14,687 | $3.84 | $56K | 731,312 |
| 2026-02-18 | Francisco David Chief Financial Officer | Grant or award | +195,312 | 701,959 | ||
| 2026-02-18 | Francisco David Chief Financial Officer | Grant or award | +43,602 | 745,561 | ||
| 2026-02-18 | Francisco David Chief Financial Officer | Shares withheld for taxes | −14,541 | $3.84 | $56K | 731,020 |
| 2026-02-18 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +111,358 | 111,358 | ||
| 2026-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −3,898 | $3.73 | $15K | 555,197 |
| 2026-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −21,412 | $3.73 | $80K | 533,785 |
| 2026-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −13,369 | $3.73 | $50K | 520,416 |
| 2026-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −13,769 | $3.73 | $51K | 506,647 |
| 2025-02-19 | Francisco David Chief Financial Officer | Grant or award | +165,156 | 559,095 | ||
| 2025-02-19 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +170,841 | 170,841 | ||
| 2025-02-16 | Francisco David Chief Financial Officer | Shares withheld for taxes | −804 | $3.70 | $3K | 393,939 |
| 2025-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −11,765 | $3.70 | $44K | 417,231 |
| 2025-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −19,528 | $3.70 | $72K | 397,703 |
| 2025-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −2,960 | $3.70 | $11K | 394,743 |
| 2024-02-21 | Francisco David Chief Financial Officer | Grant or award | +160,350 | 428,996 | ||
| 2024-02-21 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +289,915 | 289,915 | ||
| 2024-02-16 | Francisco David Chief Financial Officer | Shares withheld for taxes | −804 | $3.48 | $3K | 268,646 |
| 2024-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −18,966 | $3.68 | $70K | 272,963 |
Page 1 of 2 · 31 trades